Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.

Isoindigotin

  Cat. No.:  DC32223   Featured
Chemical Structure
476-34-6
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Isoindigotin is a potential antileukemic agent.
Cas No.: 476-34-6
Chemical Name: Isoindigo
Synonyms: 2H-Indol-2-one,3-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)-1,3-dihydro-;(3E)-3-(2-oxo-1H-indol-3-ylidene)-1H-indol-2-one;Isoindigo;Isoindigotin;(3E)-3,3'-biindole-2,2'(1H,1'H)-dione;3-(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)-1,3-dihydro-2H-indol-2-one;Indin;delta3,3'-Bioxindole;NCI60_040614;AS-82948;[3,3'-Biindolinylidene]-2,2'-dione;Isoindigo;(E)-[3,3'-biindolinylidene]-2,2'-dione;BCP32739;NSC717810;(.DELTA.3,3'-BIINDOLINE)-2,2'-DIONE;3,3'-biindole 2,2'(1h,1'h)-dione;Q27265545;SR-01000390554-1;(2-oxoindolin-3-ylidene)indolin-2-one;SCHEMBL12386233;3-(2-oxo-2,3-dihydro-1H-indol-3-ylidene)-2,3-dihydro-1H-indol-2-one;MLCPSWPIYHDOKG-BUHFOSPRSA-N;180479-95-2;AKOS001588195;Oprea1_712169;NSC-717810;CS-0030758;SCHEMBL9899740;.DELTA.3,3'-BIOXINDOLE;BDBM50342561;SR-01000390554;3-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-1,3-DIHYDRO-2H-INDOL-2-ONE;(E)-[3,3''-biindolinylidene]-2,2''-dione;2H-Indol-2-one, 3-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)-1,3-dihydro-;(3E)-3-(2-oxoindolin-3-ylidene)indolin-2-one;3-(2-hydroxy-1H-indol-3-yl)indol-2-one;6UE33XXJ1Y;476-34-6;UNII-6UE33XXJ1Y;HY-107869;SCHEMBL9899736;CHEMBL515155;(E)-[3,3'-Biindolinylidene]-2,2'-dione;AKOS032947324
SMILES: O=C1/C(=C2/C3C(=CC=CC=3)NC/2=O)/C2C(=CC=CC=2)N1
Formula: C16H10N2O2
M.Wt: 262.2628
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Cat. No. Product name Field of application
DC31074 Isopropyl myristate Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868 AZ14133346 AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865 TI17 ​​TI17​​ represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816 Nisoxetine Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641 GENZ-644282 TFA salt Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325 PSMA-617 TFA PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202 Fosaprepitant free acid Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748 O4I4 O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684 ZH8667 ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646 EB-PSMA-617 EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.
X